stars 1 stars 2 stars 3

Innoprot is a biotechnology company provider of Cell-Based Assays for drug discovery & development applications. Innoprot offers a wide range of stable cell lines and primary cells fully validated for High- Troughput Screening and High Content Screening. Stable cell lines developed by Innoprot are focused on drug discovery targeting mainly GPCRs, Nuclear hormone receptors, enzymes implicated in neurodegenerative diseases and ion channels. Innoprot has a proprietary technology for High Content Screening, which allow monitor changes in the concentrations of intracellular cAMP or Calcium by fluorescence imaging. Innoprot also offers custom assay development and High Content Screening Services, providing solutions to speed up the drug discovery campaigns of the customers.

Innoprot Questions

The Innoprot annual revenue was $6 million in 2026.

Jorge Gamiz is the Business Development Director of Innoprot.

14 people are employed at Innoprot.

The NAICS codes for Innoprot are [54, 541714, 541, 54171, 5417].

The SIC codes for Innoprot are [873, 87].

Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users